Real-world persistence and benefit–risk profile of fingolimod over 36 months in Germany
DOI: 10.1212/NXI.0000000000000548
Bj?rn Tackenberg,
C. Anne-Marie Couto,
Christian Cornelissen,
Christoph Lassek,
Holger Albrecht,
John A. Findlay,
Judith Haas,
Luisa Klotz,
Michael Lang,
Stephan Schmidt,
Tjalf Ziemssen,
on behalf of the PANGAEA study group
Abstract:
Full-Text